Abstract | BACKGROUND:
Liver transplantation (LT) is the most effective treatment for various end-stage liver diseases. However, the cellular complexity and intercellular crosstalk of the transplanted liver have constrained analyses of graft reconstruction after LT. METHODS: We established an immune-tolerated orthotopic LT mouse model to understand the physiological process of graft recovery and intercellular crosstalk. We employed single-cell RNA sequencing and cytometry by time-of-flight to comprehensively reveal the cellular landscape. RESULTS: We identified an acute and stable phase during perioperative graft recovery. Using single-cell technology, we made detailed annotations of the cellular landscape of the transplanted liver and determined dynamic modifications of these cells during LT. We found that 96% of graft-derived immune cells were replaced by recipient-derived cells from the preoperative to the stable phase. However, CD206 + MerTK + macrophages and CD49a + CD49b - natural killer cells were composed of both graft and recipient sources even in the stable phase. Intriguingly, the transcriptional profiles of these populations exhibited tissue-resident characteristics, suggesting that recipient-derived macrophages and natural killer cells have the potential to differentiate into 'tissue-resident cells' after LT. Furthermore, we described the transcriptional characteristics of these populations and implicated their role in regulating the metabolic and immune remodeling of the transplanted liver. CONCLUSIONS: In summary, this study delineated a cell atlas (type-proportion-source-time) of the transplanted liver and shed light on the physiological process of graft reconstruction and graft-recipient crosstalk.
|
Authors | Haitao Huang, Ruihan Chen, Yimou Lin, Jingyu Jiang, Shi Feng, Xueyou Zhang, Cheng Zhang, Qinghua Ji, Hui Chen, Haiyang Xie, Shusen Zheng, Qi Ling |
Journal | Transplantation
(Transplantation)
Vol. 107
Issue 4
Pg. 890-902
(04 01 2023)
ISSN: 1534-6080 [Electronic] United States |
PMID | 36413145
(Publication Type: Journal Article)
|
Copyright | Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved. |
Topics |
- Mice
- Animals
- Liver Transplantation
(adverse effects)
- End Stage Liver Disease
(surgery)
- Killer Cells, Natural
- Treatment Outcome
|